Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Shorts are covering p2 soon.
Data release is maybe 2 weeks away.
pali vs ther
Strong buy ther
Ther stock good news..will go back to .10 soon
Theralink Technologies is a precision medicine company with a nationally CLIA-certified and CAP-accredited laboratory in Golden, Colorado. Theralink’s unique and patented Reverse Phase Protein Array (RPPA) technology platform can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. Since protein signaling is responsible for the development and progression of cancer, nearly all FDA-approved cancer therapeutics target proteins, not genes. The Theralink® RPPA technology can reveal the protein drug target(s) that are essentially turned “on” in a patient’s cancer and suggest the most effective treatment plan to turn those proteins “off”. Therefore, the Theralink® RPPA technology is a critical tool that empowers oncologists with actionable information to effectively treat a cancer patient, which is often missed by standard proteomic and genomic testing.
Our commercially available Lab Developed Test (LDT), the Theralink® Assay for Breast Cancer, is currently being utilized by oncologists across the United States to assist in making the most targeted treatment plan for their patients with advanced breast cancer. In 2023, Theralink began receiving reimbursement for this test by Medicare and certain third-party payors. The Theralink® test determines which drug target(s) are present and/or activated to reveal to the oncologist which patients are predicted to be responders versus non-responders to a particular therapeutic. The test provides therapeutic recommendations to support oncologist treatment selection of the best therapy option – which may improve patient response and consequently save the healthcare system
Treatment options for other cancers too
bs you out with a loss mtf
Beautiful bottom nab,big accumulation started on 30th, institutional/insider loading, follow the $ for me
News out,phase 3 trial,float 1.36m,short 10%(152,545 shares)ZERO BORROW,(no shares to short)not optionable ,could be big runner with direct offering news expected today or ASAP (according to pr yesterday,news has been steady ,demand rising/low supply until 2.34, low risk/super high reward is the way to play
I like the chart.
pali vs Ther
Ther good buy now..its only penny 52 week it was 2$
https://www.prnewswire.com/news-releases/theralink-acquires-exclusive-landmark-immunotherapy-patent-including-biomarker-from-vanderbilt-university-301787847.html
What is the target price for Palisade Bio (PALI)?
A
The latest price target for Palisade Bio (NASDAQ: PALI) was reported by Maxim Group on March 30, 2023. The analyst firm set a price target for $50.00 expecting PALI to rise to within 12 months (a possible 2112.39% upside). 2 analyst firms have reported ratings in the last year.
Q
What is the most recent analyst rating for Palisade Bio (PALI)?
A
The latest analyst rating for Palisade Bio (NASDAQ: PALI) was provided by Maxim Group, and Palisade Bio upgraded their buy rating.
Q
When is the next analyst rating going to be posted or updated for Palisade Bio (PALI)?
A
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Palisade Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Palisade Bio was filed on March 30, 2023 so you should expect the next rating to be made available sometime around March 30, 2024.
Made money selling friday premarket at 3.60s bought some share back today.
fda news in Q2
WILL GO BACK up sooner or later
That multiplies shares by 50% ruces price 1.75
https://stockcharts.com/h-sc/ui?s=pali&p=D&yr=0&mn=6&dy=0&id=p38090673899
https://www.barchart.com/stocks/quotes/pali/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100
https://www.barchart.com/stocks/quotes/pali/opinion
Open gap at $1.65
to many shorts and fliptards
maybe dip AH and run
would be nice to see a close +4
PH
AH
let see
could do 30s with low float
3.58s back 3.40s shortie is stronge
going to fly ..... watch out shorts need do break 3.50s .. think we close
cash on hand mid 2024
phase2 data Q2
bought in 3.10s
could see a nice runner
it's now 3.46 in the premarket . Once it closes above 3.55 the 5.20 close on 12/20/22 will be next target . glad we got some at 1.65
$PALI ------- $2.99 after hours. Tomorrow will be a bigger day.WOW!!!
better get some before the rest of the train leaves the station. The high for the first quarter is 3.55 should be no problem from here.
PALI $.251 NOW, UP 48%
$PALI moving nicely, target $50 by MAXIM GROUP
$PALI target announced to $50 by Maxim Group
$PALI a monster in the making.!!!!!
Can you tell me what you think about PALI? And why so much volume a the big move lower.
Off to the races 2 million float..
$PALI: I'm shocked Madrigal still hasn't done an OFFERING
I mean............ They could clean up BIGGGGGGggggggggggg time there.
I am still bullish on April to June $MDGL puts.
I mean, they really should take advantage of getting this money while they can.
They are trading with only $150Milly in Cash and over $5Billy MarketCAP.
Take that MONEY !!!!!!!
GO $PALI
Same with HOTH they both up on offering news but it’s a gamble. Not for me will just watch
PALI has certainly delivered like a pal.....
Saw offering but fk it and buy in
Followers
|
14
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
279
|
Created
|
05/04/21
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |